CHO PHARMA INC. – Trademark Portfolio

Entity Type: 03

CHO PHARMA INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include CHOPTIMAX and CHO PHARMA. The owner is based in TAIPEI CITY.

7F, No. 99, Build. C, Ln. 130

Sec. 1, Academia Rd., Nangang Dist.

TAIPEI CITY 115 , TW

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CHO PHARMA INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does CHO PHARMA INC. have?

CHO PHARMA INC. has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 cancelled.

What trademark classes does CHO PHARMA INC. file in?

CHO PHARMA INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are CHO PHARMA INC.'s most well-known trademarks?

CHO PHARMA INC.'s registered trademark portfolio includes well-known marks such as CHOPTIMAX and CHO PHARMA. These are among 3 currently registered trademarks in the portfolio.

What is CHO PHARMA INC.'s trademark registration success rate?

CHO PHARMA INC. has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.